Intervention

Corticosteroid

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting1

Common conditions11

Lead sponsors shown7

Clinical trials

7 shown

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)NCT06780085 · 2025-05-13

Long-term Effect of Steroid on Metabolic Diseases in AsthmaticsNCT06279078 · 2023-12-30

Treating Exacerbations of Asthma With Oral Montelukast in ChildrenNCT05819541 · 2023-10-20

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS RelapsesNCT03752307 · 2019-02-15

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)NCT03050866 · 2017-02-21

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the TransplantationNCT01742624 · 2012-04-01

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationNCT00124709 · 2003-10-01

Common conditions

Asthma1 Atopic Dermatitis1 Carcinoma, Non-Small-Cell Lung1 Circulating Tumor Cell1 de Novo Kidney Transplantation1 Metastatic Prostate Cancer1 Multiple Sclerosis1 Osteoporosis Risk1 Osteoporosis, Osteopenia1 Osteoporotic Fractures1 Status Asthmaticus1

Leading sponsors

Ajou University School of Medicine1 Astellas Pharma Korea, Inc.1 Erasmus Medical Center1 Merck Sharp & Dohme LLC1 Novartis Pharmaceuticals1 University of New Mexico1 Vanderbilt University Medical Center1

Trial status mix

COMPLETED4

RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

PHASE24

PHASE42

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.